Menard Financial Group LLC Purchases 61 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Menard Financial Group LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,843 shares of the healthcare conglomerate’s stock after purchasing an additional 61 shares during the period. UnitedHealth Group comprises approximately 1.4% of Menard Financial Group LLC’s investment portfolio, making the stock its 13th biggest holding. Menard Financial Group LLC’s holdings in UnitedHealth Group were worth $1,957,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in UNH. Vanguard Group Inc. increased its position in shares of UnitedHealth Group by 0.6% in the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock valued at $41,755,280,000 after acquiring an additional 544,740 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of UnitedHealth Group by 0.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after purchasing an additional 94,641 shares in the last quarter. Capital Research Global Investors grew its stake in shares of UnitedHealth Group by 2.2% in the fourth quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock valued at $7,961,369,000 after buying an additional 324,733 shares in the last quarter. Capital International Investors raised its position in UnitedHealth Group by 4.8% during the fourth quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock worth $6,244,158,000 after acquiring an additional 542,424 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its position in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after acquiring an additional 35,533 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Trading Up 1.0 %

UNH opened at $594.32 on Monday. The company has a 50-day simple moving average of $569.08 and a 200 day simple moving average of $517.70. The stock has a market capitalization of $548.81 billion, a price-to-earnings ratio of 36.33, a P/E/G ratio of 1.64 and a beta of 0.58. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same period in the previous year, the business earned $6.14 earnings per share. The company’s revenue was up 6.4% on a year-over-year basis. Analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. UnitedHealth Group’s payout ratio is currently 51.34%.

Analyst Ratings Changes

UNH has been the subject of a number of research analyst reports. HSBC lifted their price target on UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Wells Fargo & Company increased their price target on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, September 9th. Royal Bank of Canada lifted their target price on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Finally, Robert W. Baird raised their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.